Stay updated on Tetravalent Dengue Vaccine Booster in Completed Schedule Clinical Trial
Sign up to get notified when there's something new on the Tetravalent Dengue Vaccine Booster in Completed Schedule Clinical Trial page.

Latest updates to the Tetravalent Dengue Vaccine Booster in Completed Schedule Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoChange DetectedThe ClinicalTrials.gov study record for the dengue vaccine booster trial is displayed, including its study details, results, eligibility criteria, and supporting documents, in place of a 403 error page.SummaryDifference56%

- Check15 days agoChange DetectedThe footer revision label changes from v3.7.2 to v3.8.0. The page still displays a 403 Forbidden error instead of the study record.SummaryDifference0.2%

- Check22 days agoChange DetectedA sitewide banner announces NIH’s transition from “Artificial Intelligence” to “Super Intelligence” terminology. The page itself still displays a 403 Forbidden error rather than the study record.SummaryDifference1%

- Check29 days agoChange DetectedThe 403 error display is replaced by a mostly empty ClinicalTrials.gov study-page shell; the study record details are not visible.SummaryDifference0.6%

- Check36 days agoChange DetectedThe footer’s ClinicalTrials.gov revision identifier changes from v3.7.0 to v3.7.1; the page otherwise remains a 403 error page.SummaryDifference0.2%

- Check57 days agoChange DetectedThe page now shows a 403 Forbidden error screen, replacing the study content. It includes a 403 heading and minimal navigation (such as a Home link) along with a revision note, signaling that access to the record is blocked.SummaryDifference19%

Stay in the know with updates to Tetravalent Dengue Vaccine Booster in Completed Schedule Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Tetravalent Dengue Vaccine Booster in Completed Schedule Clinical Trial page.